IP Library Granted Patent US 7,857,775
Granted Patent B2
US 7,857,775 · App. 11/079,887 · Granted Dec 28, 2010

Method for soft tissue treatment

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,857,775
App. No.
11/079,887
Granted
Dec 28, 2010
Kind
B2
Abstract

A method and system for non-invasive treatment of a soft tissue, such as adipose tissue, muscle tissue or connective tissue. The apparatus comprises an applicator configured to apply a pressure pulse to the skin surface having a negative pressure phase with respect to ambient pressure. The method comprises applying at least one pressure pulse to the skin surface overlying the soft tissue, where the pressure pulse has at least one negative pressure phase.

Claims (12)

1. A method for non-invasive treatment of a soft tissue volume, causing destruction of fat cells, with little or no damage to other cells, said method comprising:

a) applying at least one pressure pulse to a region of skin surface overlying the soft tissue volume,

the pressure pulse having negative pressure phases and positive pressure phases with respect to ambient pressure,

with the positive pressure phases being slower than the negative pressure phases; and

b) applying a temperature effector and raising the temperature of the soft tissue volume during treatment to a temperature above 37° C. by applying RF energy to the soft tissue.

2. The method according to claim 1 , wherein at least one of the negative pressure phases has an intensity between 0.1 Bar and 10 Bars below ambient pressure.

3. The method according to claim 1 , wherein at least one of the negative pressure phases has a duration between 0.1 millisecond and 100 milliseconds.

4. The method according to claim 1 , wherein at least one of the positive pressure phases has an intensity between 1 and 30 Bars above ambient pressure.

5. The method according to claim 1 , wherein at least one of the positive pressure phases has a duration between 0.01 msec to 1 msec.

6. The method according to claim 1 , further comprising applying a matching medium coupling energy delivery from an applicator to the skin surface.

7. The method according to claim 6 , wherein the matching medium is a liquid or gel.

8. The method according to claim 1 , further comprising cooling the skin surface.

Assignments (5)
NOTICE OF SUCCESSION OF AGENCY AT REEL/FRAME 059593/0269 Recorded May 29, 2026
From: BARCLAYS BANK PLC, AS PRIOR COLLATERAL AGENT
To: HSBC BANK USA, N.A., AS SUCCESSOR COLLATERAL AGENT
Reel/Frame 075648/0952 →
RELEASE (REEL 043925 / FRAME 0001) Recorded Apr 4, 2022
From: ING CAPITAL LLC
To: SYNERON MEDICAL LTD.; CANDELA CORPORATION; PRIMAEVA CORPORATION
Reel/Frame 059593/0131 →
SECURITY AGREEMENT Recorded Apr 4, 2022
From: CANDELA CORPORATION; SYNERON MEDICAL LTD.
To: BARCLAYS BANK PLC, AS COLLATERAL AGENT
Reel/Frame 059593/0269 →
SECURITY AGREEMENT Recorded Sep 20, 2017
From: SYNERON MEDICAL LTD.; CANDELA CORPORATION; PRIMAEVA CORPORATION
To: ING CAPITAL LLC, AS COLLATERAL AGENT
Reel/Frame 043925/0001 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 10, 2006
From: ROSENBERG, AVNER; KREINDEL, MICHAEL
To: SYNERON MEDICAL LTD.
Reel/Frame 017942/0316 →